0000899243-20-008529.txt : 20200316
0000899243-20-008529.hdr.sgml : 20200316
20200316203102
ACCESSION NUMBER: 0000899243-20-008529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200316
DATE AS OF CHANGE: 20200316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doberstein Stephen K
CENTRAL INDEX KEY: 0001480111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 20718972
MAIL ADDRESS:
STREET 1: 129 ELSIE STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-12
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001480111
Doberstein Stephen K
C/O DICERNA PHARMACEUTICALS, INC.
33 HAYDEN AVENUE
LEXINGTON
MA
02421
1
0
0
0
Director Stock Option (Right to Buy)
15.61
2020-03-12
4
A
0
25000
0.00
A
2030-03-11
Common Stock
25000
25000
D
This option vests as to one-third of the underlying shares on the one year anniversary of the vesting start date of February 4, 2020 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject in each case to the Reporting Person's continued service on the board of directors of the Issuer through each applicable vesting date.
/s/ John B. Green, attorney-in-fact
2020-03-16